Trials / Completed
CompletedNCT01058915
Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)
Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition Assessed by Virtual Histology in Patients With ST-Segment Elevation Acute Myocardial Infarction (VIRHISTAMI)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 87 (actual)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 81 Years
- Healthy volunteers
- Not accepted
Summary
In patients with ST-segment elevation acute myocardial infarction (STEMI) increased LDL-cholesterol reduction (rosuvastatin 40 mg) will provide incremental plaque stabilization (changes in plaque composition) and plaque regression over 12 months beyond the benefit of moderate LDL-cholesterol reduction (rosuvastatin 5 mg) (assessed by IVUS and VH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin 5mg | Rosuvastatin 5mg/day |
| DRUG | Rosuvastatin 40mg | Rosuvastatin 40mg/day |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2010-01-29
- Last updated
- 2010-01-29
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01058915. Inclusion in this directory is not an endorsement.